Human ICG1 Monoclonal Antibody Against Trem2 clinical trials

A Multicenter, Long-term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants with Alzheimer's Disease

This study is looking at a new treatment called AL002 for Alzheimer's disease. Researchers want to see if it's safe, how well people can cope with it, and if it helps reduce symptoms over a long time. It’s for adults diagnosed with Alzheimer's.